|
Volumn 33, Issue 7-8, 2001, Pages 3624-3625
|
Cytomegalovirus infection after liver transplantation using different prophylaxes
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
GANCICLOVIR;
GLOBULIN;
HYPERIMMUNE GLOBULIN;
IMMUNOGLOBULIN ANTIBODY;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
ANTIBODY TITER;
ARTICLE;
BIOPSY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG MECHANISM;
GRAFT REJECTION;
HEPATITIS;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
LEUKOPENIA;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MORTALITY;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SUPERINFECTION;
SURVIVAL;
VIRUS INFECTION;
VIRUS PNEUMONIA;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
GANCICLOVIR;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
METHYLPREDNISOLONE;
MONITORING, PHYSIOLOGIC;
PHOSPHOPROTEINS;
POSTOPERATIVE COMPLICATIONS;
VIRAL MATRIX PROTEINS;
|
EID: 0035671403
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02559-3 Document Type: Article |
Times cited : (3)
|
References (6)
|